StockData

Rafael Holdings, Inc. (RFL) stock

RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 5/30
$0.91−0.06 (-5.84%)

Close on Nov 17, 2026Market cap $47.67MP/E –Yield –

Rafael r&d expenses

Research and development expenses are spending on new products and technology.

Rafael's R&D Expenses for the twelve months ending Jul 31, 2026 was $24.33M, up 89.8% year over year. For fiscal 2026 it was $24.33M, up 89.8% from the year before. The highest annual figure on record is $24.33M in fiscal 2026.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jul 31, 2026$24.33M+89.8%
FY2025Jul 31, 2025$12.82M+207.5%
FY2024Jul 31, 2024$4.17M-33.9%
FY2023Jul 31, 2023$6.31M-27.8%
FY2022Jul 31, 2022$8.74M+78.2%
FY2021Jul 31, 2021$4.91M+105.2%
FY2020Jul 31, 2020$2.39M+132.8%
FY2019Jul 31, 2019$1.03M+3.2%
FY2018Jul 31, 2018$995.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 2026$7.47M+3118.5%
Q3 FY2026CQ1 2026Apr 30, 2026$4.85M+61.6%
Q2 FY2026CQ4 2025Jan 31, 2026$4.53M+378.2%
Q1 FY2026CQ3 2025Oct 31, 2025$7.48M+464.4%
Q4 FY2025CQ2 2025Jul 31, 2025$232.00K-85.0%
Q3 FY2025CQ1 2025Apr 30, 2025$3.00M+96.8%
Q2 FY2025CQ4 2024Jan 31, 2025$947.00K+54.7%
Q1 FY2025CQ3 2024Oct 31, 2024$1.33M+171.2%
Q4 FY2024CQ2 2024Jul 31, 2024$1.54M+21.9%
Q3 FY2024CQ1 2024Apr 30, 2024$1.53M+106.2%
Q2 FY2024CQ4 2023Jan 31, 2024$612.00K-72.5%
Q1 FY2024CQ3 2023Oct 31, 2023$489.00K-76.5%
Q4 FY2023CQ2 2023Jul 31, 2023$1.27M-31.2%
Q3 FY2023CQ1 2023Apr 30, 2023$740.00K-47.6%
Q2 FY2023CQ4 2022Jan 31, 2023$2.23M-33.3%
Q1 FY2023CQ3 2022Oct 31, 2022$2.08M-3.3%
Q4 FY2022CQ2 2022Jul 31, 2022$1.84M+17.9%
Q3 FY2022CQ1 2022Apr 30, 2022$1.41M+12.0%
Q2 FY2022CQ4 2021Jan 31, 2022$3.34M+112.7%
Q1 FY2022CQ3 2021Oct 31, 2021$2.15M+318.1%
Q4 FY2021CQ2 2021Jul 31, 2021$1.56M+46.8%
Q3 FY2021CQ1 2021Apr 30, 2021$1.26M+99.1%
Q2 FY2021CQ4 2020Jan 31, 2021$1.57M+250.0%
Q1 FY2021CQ3 2020Oct 31, 2020$515.00K+110.2%
Q4 FY2020CQ2 2020Jul 31, 2020$1.06M+1264.1%
Q3 FY2020CQ1 2020Apr 30, 2020$634.00K+111.3%
Q2 FY2020CQ4 2019Jan 31, 2020$448.00K+62.3%
Q1 FY2020CQ3 2019Oct 31, 2019$245.00K-34.3%
Q4 FY2019CQ2 2019Jul 31, 2019$78.00K–
Q3 FY2019CQ1 2019Apr 30, 2019$300.00K–
Q2 FY2019CQ4 2018Jan 31, 2019$276.00K–
Q1 FY2019CQ3 2018Oct 31, 2018$373.00K–

More Rafael figures

See a number that looks wrong?